Abstract

Background

Patients with inflammatory bowel disease (IBD) frequently undergo multiple computed tomography (CT) examinations. With the widespread availability of magnetic resonance imaging (MRI), it is unclear whether the use of CTs in IBD has declined. We aimed to analyze the trends of CT and MRI use in a large cohort of IBD patients in a 10-year period.

Methods

We retrospectively analyzed adults ≥18 years of age using a de-identified database, IBM Explorys. Patients with ≥1 CT of the abdomen (± pelvis) or MRI of the abdomen (± pelvis) at least 30 days after the diagnosis of Crohn’s disease (CD) or ulcerative colitis (UC) were included. We examined the factors associated with patients undergoing multiple CTs (≥5 CTs of the abdomen) and performed a trend analysis from 2010 to 2019.

Results

Among 176 110 CD and 143 460 UC patients, those with ≥1 CT of the abdomen annually increased from 2010 to 2019 with mean annual percentage change of +3.6% for CD and +4.9% for UC. Similarly, annual percentage change for patients with ≥1 MRI (CD: +15.6%; UC: +22.8%) showed a rising trend. There was a 3.8% increase in CD patients receiving ≥5 CTs of the abdomen annually compared with a 2.4% increase among UC patients in the 10-year period. Age ≥50 years, men, African Americans, public insurance payors, body mass index ≥30kg/m2, and smoking history were associated with ≥5 CTs.

Conclusions

There is a considerable increase in the number of CT scans performed in IBD patients. Further studies can explore factors influencing the use of CT and MRI of the abdomen in IBD patients.

Lay Summary

The proportion of inflammatory bowel disease patients with ≥5 computed tomographies of the abdomen annually has increased by 2.4%-3.8% from 2010 to 2019. Age ≥50 years, men, African Americans, public insurance payors, body mass index ≥30kg/m2, and smoking history were associated with ≥5 computed tomographies of the abdomen annually.

Introduction

Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal system. It has a relapsing remitting course in which medical imaging plays an important role in the diagnosis of the disease, detection of complications, and assessment of the treatment response. Computed tomography (CT) scans have played an important role in the diagnosis and management of IBD for several decades. However, it has been shown that 1 in 10 IBD patients is at risk of exposure to high diagnostic medical radiation,1 and three-quarters of the radiation exposure comes from CT scans.2 While the average radiation exposure from natural radiation is 1-3 mSv, the median effective dose of an abdominal CT scan is about 8-10 mSv, with a higher radiation dose for CT with contrast and multiphase CTs.3,4 Radiation from CT scans can induce chromosome aberration including translocation, dicentric rings, insertion, and breaks in human chromosomes.5 Cumulative radiation exposure at a young age increases the risk of a variety of solid and hematological malignancies.6,7 Because many IBD patients are diagnosed at a young age,8 they are exposed to a higher amount of radiation early in their life and are at a risk for cumulative radiation exposure that is associated with stochastic risks.9 Patients with IBD are more vulnerable to ionizing radiation than the general population due to inherent neoplastic risks from chronic inflammation and immunosuppressive therapy.10

Magnetic resonance imaging (MRI) allows for cross-sectional imaging in multiple planes in the absence of ionizing radiation11 and has emerged as an important alternative imaging technique to CT scans. Several studies have reported comparable efficacy of CT and MR enterography (MRE) in assessing small bowel disease activity in Crohn’s disease (CD).12 MRE also has the advantage of providing dynamic assessment of small bowel motility by which it can distinguish active inflammatory disease from chronic fibrostenotic disease.13,14 Currently, MRE is recommended over CT enterography (CTE) in estimating response to medical treatment in asymptomatic CD15 as well as in evaluating CD in young patients (<35 years of age).16,17 Similarly, pelvic MRI is the preferred modality in the assessment of perianal and perirectal complications of CD.18 In the light of these considerations, the use of CT scans in IBD is expected to decrease. Because data on the recent utilization of CT and MRI in IBD are limited, we aimed to analyze the trends of CT and MRI use in a large cohort of IBD patients over 10 years.

Methods

Database

This is a retrospective cross-sectional observational study performed using a de-identified database, IBM Explorys. Explorys extracts electronic health record (EHR) data from participating intuitions using health data gateway server behind their firewall. These data are then de-identified to meet the standards of the Health Insurance Portability and Accountability Act. The EHR data are then categorized to facilitate searching and indexing.19,20 International Classification of Diseases diagnoses are mapped into SNOMED CT (Systematized Nomenclature of Medicine–Clinical Terms) hierarchy, and procedures are indexed using Current Procedural Terminology.19 This Health Insurance Portability and Accountability Act–enabled platform unifies de-identified clinical data across 26 healthcare networks comprising 360 hospitals and over 64 million unique patients from academic and community hospitals.19 Explorys rounds to the nearest 10 for statistical de-identification. Because Explorys aggregates data without any patient identifiable information, it does not require approval from the individual institutional review board.

Study Population

Adults ≥18 years of age who had a hospital encounter (inpatient, outpatient, surgery, procedure, emergency or urgent care visit) in 2010-2019 were reviewed in the study. In this population, SNOMED CT diagnosis codes for ulcerative colitis (UC) and CD were employed to identify the study population. Among those with UC or CD, those who underwent ≥1 CT of the abdomen (with or without pelvis, with or without contrast) or MRI of the abdomen (with or without pelvis, with or without contrast) at least 30 days after UC or CD diagnosis were analyzed on a yearly basis. Demographic characteristics such as 10-year age range, sex, ethnicity, race, insurance, obesity, smoking, and IBD complications such as fistula of intestine, perforation of intestine, small bowel obstruction, abscess of intestine, and perianal abscess were included. Individuals were considered obese if they had at least 1 body mass index (BMI) in the obese category (BMI ≥30kg/m2).

Statistical Analysis

The primary aim of the study was to analyze the yearly trends of IBD individuals with ≥1 CT of the abdomen and ≥1 MRI of the abdomen in the 10-year period. The secondary aim was to determine the percentage of IBD individuals who underwent ≥5 abdominal CTs during the study period. The prevalence of CD and UC in the study population was calculated by dividing the individuals with CD or UC who had at least 1 of the reviewed encounters by the total number of individuals who had an encounter during the study period. A demographic comparison was performed with individuals who had ≥5 CT scans (multiple CT scans) and those who had <5 CT scans for CD and UC using univariate chi-square test. The yearly trend from 2010 to 2019 was performed using Cochrane-Armitage test for the following (1) individuals with CD and UC who underwent ≥1 CT and ≥1 MRI; (2) individuals with 1-4 CT, ≥5 CT, and ≥10 CT scans in a year; and (3) individuals who developed IBD-related complications. Statistical analyses were performed using Microsoft Excel 2016 (Microsoft Corporation, Redmond, WA) and Addinsoft xlstat 2019.1 (Addinsoft, Paris, France). A P value <.05 was considered statistically significant.

Results

Among 39 717 520 adults, 176 110 (0.44%) with CD and 143 460 (0.36%) with UC had at least one of the studied encounters in the last 10 years. About 9.4% of the individuals with IBD had ≥5 abdominal CTs in the last 10 years, with CD significantly higher than UC (10.6% vs 8.2%; P<.001). There was a significant increase in the percentage of individuals with ≥1 CT of the abdomen and MRI of the abdomen from 2010 to 2019.

Demographics

The baseline demographics between the CD and UC study population are shown in Table 1. Demographic details of individuals with ≥5 CT scans were compared with those with <5 CTs of the abdomen in Table 2. Age >50 years, men, African Americans, public insurance holders (Medicare and Medicaid), smoking, and BMI ≥30kg/m2 were significantly associated with higher rates of abdominal CTs in CD and UC.

Table 1.

Demographics of study population

Variable Crohn’s Disease (n = 176 110) Ulcerative Colitis (n = 143 460)
Age
 <20 y1820 (1)910 (0.7)
 20-29 y22 690 (13)14 460 (10)
 30-39 y34 470 (20)24 470 (17)
 40-49 y26 010 (15)21 340 (15)a
 ≥50 y91 120 (52)82 280 (57)
Sex
 Male6962 (40)58 440 (41)
 Female106 490 (60)85 020 (59)
Race/ethnicity
 Non-Hispanic138 150 (88)113 340 (79)
 Hispanic11 110 (8)10 220 (7)
 Caucasian141 360 (80)116 680 (81)
 African American15 350 (8)10 410 (7)
Insurance
 Medicare30 910 (20)33 950 (24)
 Medicaid23 320 (13)15 580 (11)
 Private110 550 (63)84 700 (59)
 Self-pay11 330 (6)8430 (6)a
Smoking78 620 (45)59 020 (41)
Obese BMI64 910 (37)64 910 (39)
Variable Crohn’s Disease (n = 176 110) Ulcerative Colitis (n = 143 460)
Age
 <20 y1820 (1)910 (0.7)
 20-29 y22 690 (13)14 460 (10)
 30-39 y34 470 (20)24 470 (17)
 40-49 y26 010 (15)21 340 (15)a
 ≥50 y91 120 (52)82 280 (57)
Sex
 Male6962 (40)58 440 (41)
 Female106 490 (60)85 020 (59)
Race/ethnicity
 Non-Hispanic138 150 (88)113 340 (79)
 Hispanic11 110 (8)10 220 (7)
 Caucasian141 360 (80)116 680 (81)
 African American15 350 (8)10 410 (7)
Insurance
 Medicare30 910 (20)33 950 (24)
 Medicaid23 320 (13)15 580 (11)
 Private110 550 (63)84 700 (59)
 Self-pay11 330 (6)8430 (6)a
Smoking78 620 (45)59 020 (41)
Obese BMI64 910 (37)64 910 (39)

Values are n (%). P<.001 for all comparisons, unless otherwise indicated.

Abbreviation: BMI, body mass index.

P < 0.001 except a where P = 0.41.

Table 1.

Demographics of study population

Variable Crohn’s Disease (n = 176 110) Ulcerative Colitis (n = 143 460)
Age
 <20 y1820 (1)910 (0.7)
 20-29 y22 690 (13)14 460 (10)
 30-39 y34 470 (20)24 470 (17)
 40-49 y26 010 (15)21 340 (15)a
 ≥50 y91 120 (52)82 280 (57)
Sex
 Male6962 (40)58 440 (41)
 Female106 490 (60)85 020 (59)
Race/ethnicity
 Non-Hispanic138 150 (88)113 340 (79)
 Hispanic11 110 (8)10 220 (7)
 Caucasian141 360 (80)116 680 (81)
 African American15 350 (8)10 410 (7)
Insurance
 Medicare30 910 (20)33 950 (24)
 Medicaid23 320 (13)15 580 (11)
 Private110 550 (63)84 700 (59)
 Self-pay11 330 (6)8430 (6)a
Smoking78 620 (45)59 020 (41)
Obese BMI64 910 (37)64 910 (39)
Variable Crohn’s Disease (n = 176 110) Ulcerative Colitis (n = 143 460)
Age
 <20 y1820 (1)910 (0.7)
 20-29 y22 690 (13)14 460 (10)
 30-39 y34 470 (20)24 470 (17)
 40-49 y26 010 (15)21 340 (15)a
 ≥50 y91 120 (52)82 280 (57)
Sex
 Male6962 (40)58 440 (41)
 Female106 490 (60)85 020 (59)
Race/ethnicity
 Non-Hispanic138 150 (88)113 340 (79)
 Hispanic11 110 (8)10 220 (7)
 Caucasian141 360 (80)116 680 (81)
 African American15 350 (8)10 410 (7)
Insurance
 Medicare30 910 (20)33 950 (24)
 Medicaid23 320 (13)15 580 (11)
 Private110 550 (63)84 700 (59)
 Self-pay11 330 (6)8430 (6)a
Smoking78 620 (45)59 020 (41)
Obese BMI64 910 (37)64 910 (39)

Values are n (%). P<.001 for all comparisons, unless otherwise indicated.

Abbreviation: BMI, body mass index.

P < 0.001 except a where P = 0.41.

Table 2.

Univariate analysis of risk factors of high diagnostic medical radiation (≥5 abdominal CTs)

Variable Crohn’s DiseaseUlcerative Colitis
≥5 CTs (n=18 580) <5 CTs (n = 157 530) OR (95% CI) ≥5 CTs (n = 11 800) <5 CTs (n=131 660) OR (95%CI)
Age
 <50 y8370 (45)80 340 (51)11820 (15)19 520 15)1
 ≥50 y10 210 (55)77 190 (49)1.26 (1.23-1.30)2150 (18)21 760 (17)4.36 (4.14-4.58)
Sex
 Male7390 (60)58 390 (37)1.26 (1.23-1.30)6960 (59)51 450 (39)2.57 (2.49-2.65)
 Female11 190 (40)99 100 (63)14840 (41)80 180 (61)1
Race/ethnicity
 Non-Hispanic16 660 (90)121 490 (77)110 620 (64)102 720 (78)1
 Hispanic690 (4)11 110 (7)0.43 (0.42-0.49)500 (4.2)9720 (7)0.50 (0.45-0.55)
 Caucasian15 900 (86)125 460 (80)110 290 (87)106 390 (81)1
 African American2180 (12)13 170 (8)1.31 (1.25-1.37)1170 (10)9240 (7)1.31 (1.23-1.40)
Insurance
 Medicare6130 (33)30 910 (20)2.24 (2.16-2.32)4500 (38)29 450 (22)2.38 (2.28-2.48)
 Medicaid3650 (20)19 370 (12)2.12 (2.04-2.22)1800 (15)13 780 (11)2.03 (1.92-2.15)
 Private8150 (44)91 860 (58)15110 (43)79 590 (61)1
 Self-pay650 (3)10 680 (7)0.69 (0.63-0.75)390 (3)8040 (6)0.76 (0.68-0.84)
Smoking11 740 (63)66 880 (43)2.33 (1.25-2.40)7050 (60)51 970 (39)2.28 (2.19-2.37)
Obesity9780 (53)55 130 (35)2.06 (2.00-2.13)6520 (55.3)58 390 (44)1.55 (1.49-1.61)
Variable Crohn’s DiseaseUlcerative Colitis
≥5 CTs (n=18 580) <5 CTs (n = 157 530) OR (95% CI) ≥5 CTs (n = 11 800) <5 CTs (n=131 660) OR (95%CI)
Age
 <50 y8370 (45)80 340 (51)11820 (15)19 520 15)1
 ≥50 y10 210 (55)77 190 (49)1.26 (1.23-1.30)2150 (18)21 760 (17)4.36 (4.14-4.58)
Sex
 Male7390 (60)58 390 (37)1.26 (1.23-1.30)6960 (59)51 450 (39)2.57 (2.49-2.65)
 Female11 190 (40)99 100 (63)14840 (41)80 180 (61)1
Race/ethnicity
 Non-Hispanic16 660 (90)121 490 (77)110 620 (64)102 720 (78)1
 Hispanic690 (4)11 110 (7)0.43 (0.42-0.49)500 (4.2)9720 (7)0.50 (0.45-0.55)
 Caucasian15 900 (86)125 460 (80)110 290 (87)106 390 (81)1
 African American2180 (12)13 170 (8)1.31 (1.25-1.37)1170 (10)9240 (7)1.31 (1.23-1.40)
Insurance
 Medicare6130 (33)30 910 (20)2.24 (2.16-2.32)4500 (38)29 450 (22)2.38 (2.28-2.48)
 Medicaid3650 (20)19 370 (12)2.12 (2.04-2.22)1800 (15)13 780 (11)2.03 (1.92-2.15)
 Private8150 (44)91 860 (58)15110 (43)79 590 (61)1
 Self-pay650 (3)10 680 (7)0.69 (0.63-0.75)390 (3)8040 (6)0.76 (0.68-0.84)
Smoking11 740 (63)66 880 (43)2.33 (1.25-2.40)7050 (60)51 970 (39)2.28 (2.19-2.37)
Obesity9780 (53)55 130 (35)2.06 (2.00-2.13)6520 (55.3)58 390 (44)1.55 (1.49-1.61)

Values are n (%), unless otherwise indicated. P<.001 for all comparisons.

Abbreviations: CI, confidence interval; CT, computed tomography; OR, odds ratio.

Table 2.

Univariate analysis of risk factors of high diagnostic medical radiation (≥5 abdominal CTs)

Variable Crohn’s DiseaseUlcerative Colitis
≥5 CTs (n=18 580) <5 CTs (n = 157 530) OR (95% CI) ≥5 CTs (n = 11 800) <5 CTs (n=131 660) OR (95%CI)
Age
 <50 y8370 (45)80 340 (51)11820 (15)19 520 15)1
 ≥50 y10 210 (55)77 190 (49)1.26 (1.23-1.30)2150 (18)21 760 (17)4.36 (4.14-4.58)
Sex
 Male7390 (60)58 390 (37)1.26 (1.23-1.30)6960 (59)51 450 (39)2.57 (2.49-2.65)
 Female11 190 (40)99 100 (63)14840 (41)80 180 (61)1
Race/ethnicity
 Non-Hispanic16 660 (90)121 490 (77)110 620 (64)102 720 (78)1
 Hispanic690 (4)11 110 (7)0.43 (0.42-0.49)500 (4.2)9720 (7)0.50 (0.45-0.55)
 Caucasian15 900 (86)125 460 (80)110 290 (87)106 390 (81)1
 African American2180 (12)13 170 (8)1.31 (1.25-1.37)1170 (10)9240 (7)1.31 (1.23-1.40)
Insurance
 Medicare6130 (33)30 910 (20)2.24 (2.16-2.32)4500 (38)29 450 (22)2.38 (2.28-2.48)
 Medicaid3650 (20)19 370 (12)2.12 (2.04-2.22)1800 (15)13 780 (11)2.03 (1.92-2.15)
 Private8150 (44)91 860 (58)15110 (43)79 590 (61)1
 Self-pay650 (3)10 680 (7)0.69 (0.63-0.75)390 (3)8040 (6)0.76 (0.68-0.84)
Smoking11 740 (63)66 880 (43)2.33 (1.25-2.40)7050 (60)51 970 (39)2.28 (2.19-2.37)
Obesity9780 (53)55 130 (35)2.06 (2.00-2.13)6520 (55.3)58 390 (44)1.55 (1.49-1.61)
Variable Crohn’s DiseaseUlcerative Colitis
≥5 CTs (n=18 580) <5 CTs (n = 157 530) OR (95% CI) ≥5 CTs (n = 11 800) <5 CTs (n=131 660) OR (95%CI)
Age
 <50 y8370 (45)80 340 (51)11820 (15)19 520 15)1
 ≥50 y10 210 (55)77 190 (49)1.26 (1.23-1.30)2150 (18)21 760 (17)4.36 (4.14-4.58)
Sex
 Male7390 (60)58 390 (37)1.26 (1.23-1.30)6960 (59)51 450 (39)2.57 (2.49-2.65)
 Female11 190 (40)99 100 (63)14840 (41)80 180 (61)1
Race/ethnicity
 Non-Hispanic16 660 (90)121 490 (77)110 620 (64)102 720 (78)1
 Hispanic690 (4)11 110 (7)0.43 (0.42-0.49)500 (4.2)9720 (7)0.50 (0.45-0.55)
 Caucasian15 900 (86)125 460 (80)110 290 (87)106 390 (81)1
 African American2180 (12)13 170 (8)1.31 (1.25-1.37)1170 (10)9240 (7)1.31 (1.23-1.40)
Insurance
 Medicare6130 (33)30 910 (20)2.24 (2.16-2.32)4500 (38)29 450 (22)2.38 (2.28-2.48)
 Medicaid3650 (20)19 370 (12)2.12 (2.04-2.22)1800 (15)13 780 (11)2.03 (1.92-2.15)
 Private8150 (44)91 860 (58)15110 (43)79 590 (61)1
 Self-pay650 (3)10 680 (7)0.69 (0.63-0.75)390 (3)8040 (6)0.76 (0.68-0.84)
Smoking11 740 (63)66 880 (43)2.33 (1.25-2.40)7050 (60)51 970 (39)2.28 (2.19-2.37)
Obesity9780 (53)55 130 (35)2.06 (2.00-2.13)6520 (55.3)58 390 (44)1.55 (1.49-1.61)

Values are n (%), unless otherwise indicated. P<.001 for all comparisons.

Abbreviations: CI, confidence interval; CT, computed tomography; OR, odds ratio.

Trend Analysis

The percentage of individuals who had ≥1 CT of the abdomen significantly increased from 2010 to 2019 (CD: 10.2% vs 13.9%; UC: 6.6% vs 10.0%), and the mean annual percentage change was +3.6% for CD and +4.9% for UC. Similar increase was noted for individuals who had ≥1 MRI (CD: 1.5% vs 4.1%; UC: 0.7% vs 2.3), with a higher mean annual percentage change (CD: +15.6%, UC: +22.8% (Figure 1). We found a significant increase in the percentage of individuals with ≥5 CT scans (CD: 1.3% vs 5.1%; UC: 1% vs 3.4%) and ≥10 CT scans (CD: 0.3% vs 1.5%; UC: 0.2% vs 0.9%) from 2010 to 2019 (Table 3), with P<.001 for the previous comparisons. However, the trend was not significant for those with 1-4 CTs. Among those with ≥5 CTs per year, there was no significant difference in the percentage of individuals diagnosed with complications between 2010 and 2019 (CD: 12.1% vs 12.0%; P=.959; UC: 11.1% vs 8.4%; P=.237) (Table 4).

Table 3.

Quantification of abdominal CTs from 2010 to 2019

Year Crohn’s DiseaseUlcerative Colitis
1-4 CTs≥5 CTs≥10 CTs1-4 CTs≥5 CTs≥10 CTs
n % n % n % n % n % n %
201022608.893301.30800.3110705.671800.95400.21
201127308.435301.641300.4013205.412501.02600.25
201237608.898602.032400.5717905.594401.371100.34
201346509.3312302.473200.6423506.155601.471400.37
201458609.8916102.724500.7630206.757501.681900.42
201563509.7017902.735200.7934406.778801.732100.41
201658808.9121403.245900.8933806.3610802.032800.53
201745108.4718803.535601.0526106.0310402.402700.62
201832207.7719504.715601.3522306.5510703.142700.79
201933208.7819205.085801.5321206.6710703.372900.91
Year Crohn’s DiseaseUlcerative Colitis
1-4 CTs≥5 CTs≥10 CTs1-4 CTs≥5 CTs≥10 CTs
n % n % n % n % n % n %
201022608.893301.30800.3110705.671800.95400.21
201127308.435301.641300.4013205.412501.02600.25
201237608.898602.032400.5717905.594401.371100.34
201346509.3312302.473200.6423506.155601.471400.37
201458609.8916102.724500.7630206.757501.681900.42
201563509.7017902.735200.7934406.778801.732100.41
201658808.9121403.245900.8933806.3610802.032800.53
201745108.4718803.535601.0526106.0310402.402700.62
201832207.7719504.715601.3522306.5510703.142700.79
201933208.7819205.085801.5321206.6710703.372900.91

Abbreviation: CT, computed tomography.

Table 3.

Quantification of abdominal CTs from 2010 to 2019

Year Crohn’s DiseaseUlcerative Colitis
1-4 CTs≥5 CTs≥10 CTs1-4 CTs≥5 CTs≥10 CTs
n % n % n % n % n % n %
201022608.893301.30800.3110705.671800.95400.21
201127308.435301.641300.4013205.412501.02600.25
201237608.898602.032400.5717905.594401.371100.34
201346509.3312302.473200.6423506.155601.471400.37
201458609.8916102.724500.7630206.757501.681900.42
201563509.7017902.735200.7934406.778801.732100.41
201658808.9121403.245900.8933806.3610802.032800.53
201745108.4718803.535601.0526106.0310402.402700.62
201832207.7719504.715601.3522306.5510703.142700.79
201933208.7819205.085801.5321206.6710703.372900.91
Year Crohn’s DiseaseUlcerative Colitis
1-4 CTs≥5 CTs≥10 CTs1-4 CTs≥5 CTs≥10 CTs
n % n % n % n % n % n %
201022608.893301.30800.3110705.671800.95400.21
201127308.435301.641300.4013205.412501.02600.25
201237608.898602.032400.5717905.594401.371100.34
201346509.3312302.473200.6423506.155601.471400.37
201458609.8916102.724500.7630206.757501.681900.42
201563509.7017902.735200.7934406.778801.732100.41
201658808.9121403.245900.8933806.3610802.032800.53
201745108.4718803.535601.0526106.0310402.402700.62
201832207.7719504.715601.3522306.5510703.142700.79
201933208.7819205.085801.5321206.6710703.372900.91

Abbreviation: CT, computed tomography.

Table 4.

Trends of individuals with IBD complications and ≥5 CTs of the abdomen from 2010 to 2019

Year Crohn’s Disease With ≥5 CTsUlcerative Colitis With ≥5 CTs
Total Complications Total Complications
201033040 (12.1)18020 (11.1)
201163080 (12.7)25020 (8.0)
2012860110 (12.8)44030 (6.8)
20131230170 (13.8)56050 (8.9)
20141610200 (12.4)75060 (8.0)
20151790240 (13.4)88080 (9.1)
20162140280 (13.1)1080100 (9.3)
20171880260 (13.8)104070 (6.7)
20181950250 (12.8)107080 (7.5)
20191920230 (12)107090 (8.4)
Year Crohn’s Disease With ≥5 CTsUlcerative Colitis With ≥5 CTs
Total Complications Total Complications
201033040 (12.1)18020 (11.1)
201163080 (12.7)25020 (8.0)
2012860110 (12.8)44030 (6.8)
20131230170 (13.8)56050 (8.9)
20141610200 (12.4)75060 (8.0)
20151790240 (13.4)88080 (9.1)
20162140280 (13.1)1080100 (9.3)
20171880260 (13.8)104070 (6.7)
20181950250 (12.8)107080 (7.5)
20191920230 (12)107090 (8.4)

Values are n (%), unless otherwise indicated.

Abbreviations: CT, computed tomography; IBD, inflammatory bowel disease.

Table 4.

Trends of individuals with IBD complications and ≥5 CTs of the abdomen from 2010 to 2019

Year Crohn’s Disease With ≥5 CTsUlcerative Colitis With ≥5 CTs
Total Complications Total Complications
201033040 (12.1)18020 (11.1)
201163080 (12.7)25020 (8.0)
2012860110 (12.8)44030 (6.8)
20131230170 (13.8)56050 (8.9)
20141610200 (12.4)75060 (8.0)
20151790240 (13.4)88080 (9.1)
20162140280 (13.1)1080100 (9.3)
20171880260 (13.8)104070 (6.7)
20181950250 (12.8)107080 (7.5)
20191920230 (12)107090 (8.4)
Year Crohn’s Disease With ≥5 CTsUlcerative Colitis With ≥5 CTs
Total Complications Total Complications
201033040 (12.1)18020 (11.1)
201163080 (12.7)25020 (8.0)
2012860110 (12.8)44030 (6.8)
20131230170 (13.8)56050 (8.9)
20141610200 (12.4)75060 (8.0)
20151790240 (13.4)88080 (9.1)
20162140280 (13.1)1080100 (9.3)
20171880260 (13.8)104070 (6.7)
20181950250 (12.8)107080 (7.5)
20191920230 (12)107090 (8.4)

Values are n (%), unless otherwise indicated.

Abbreviations: CT, computed tomography; IBD, inflammatory bowel disease.

A, Trends of computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen or pelvis in Crohn’s disease. B, Trends of CT and MRI of the abdomen or pelvis in ulcerative colitis.
Figure 1.

A, Trends of computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen or pelvis in Crohn’s disease. B, Trends of CT and MRI of the abdomen or pelvis in ulcerative colitis.

Discussion

Using a large population-level database, we showed that the percentage of IBD patients receiving abdominal CTs significantly increased from 2010 to 2019 despite the considerable increase in the availability of MRI of the abdomen. A total of 9.4% of adults with IBD had ≥5 abdominal CTs in the 10-year study period, and there was at least a 3-fold increase in this percentage between 2010 and 2019.

Radiation in CD vs UC

CD often presents earlier than UC.8 CD, being a transmural disease, has higher complication rates in the form of strictures, fistulae, and abscesses compared with UC.21 CD has been identified as an independent risk factor of increased radiation, and CD patients are exposed to 1.3-4 times higher diagnostic medical radiation than UC patients, in line with our study results.2,22-24 A recent population-based study by Nguyen et al25 showed that 15.6% of CD patients were exposed to a cumulative radiation >50 mSv compared with 6.2% of UC patients over a 5-year period. In contrary to most studies, Israeli et al26 did not find significant difference in the cumulative effective dose between UC and CD over an 80-month period. However, this study also represents data from a relatively high-risk group of IBD patients who presented to the emergency department (ED) with gastrointestinal complaints only.

Risk Factors of Undergoing Multiple CT Scans

Age ≥57 years was shown as an independent risk factor of higher radiation.23 In our study, older age (≥50 years) was a significant risk factor for undergoing multiple CTs in CD (odds ratio, 1.26) and UC (odds ratio, 4.36), the association being stronger in UC. The difference could be due to UC patients presenting later than CD8 or to providers being more likely to order CT scans in older individuals. Men with CD have higher risk of penetrating disease, stricturing disease, perianal manifestation,27 and major abdominal surgeries compared with women.28 This was reflected as a positive trend for receiving higher number of CTs in men with CD similar to the literature.23,29 Additionally, our study showed an elevated risk of undergoing multiple CTs for men with UC. It is likely that concern for pregnancy affected provider decisions in ordering CT scans for women of the reproductive age group.

While CD and men are established risk factors of high diagnostic medical radiation in IBD, we found that smoking and obesity are additional risk factors of undergoing multiple CTs that have not been extensively described in prior studies. Current smoking status is associated with 1.7 times higher risk of abdominal surgeries compared with never smokers.28 Obese patients have more clinic visits, hospitalizations, and flares than normal-weight individuals.30 These factors likely influenced more CT imaging in this population.

Trends

In our study, 7.6% of IBD patients (55% CD, 45% UC) had ≥5 abdominal CTs in 5 years (2015-2019). While the cause of this increasing trend remains unclear, individuals with ≥5 CTs in a year did not have an increasing trend in complication rates from 2010 to 2019. This shows that the increase in severity or complication rate cannot fully account for this rising trend. However, it is also possible that they were performed to assess disease activity and treatment response in individuals with severe disease.

CT is available in >95% of institutions across the United States, with 94% offering 24/7 accessibility to the ED.31 Patients with IBD get their CTs either from the ED or from an inpatient setting more than a quarter of the time.29 Aside from conventional CTs, CTE is increasingly popular in the management of IBD patients, and its use increased by 840% from 2003 to 2007.29 While CT appears to be the most accessible imaging technique in the ED, there is a possibility that it is overutilized.32 There are numerous factors such as ambiguity in clinical presentation, uncertainty in decision making, provider type, practices adopted in training, and medical liability risk that have been reported to influence ordering CT studies.33,34 Thus, the efficacy of the study, encounter location, test availability, provider type, personal preferences, and medical liability risk could collectively play a role in the increasing rates of CT scans and should to be studied in the future to get a thorough picture of the possible etiologies. Further, newer techniques in imaging such as iterative reconstruction algorithms can lead to noise reduction and aid in radiation reduction compared with conventional filtered back projection in abdominal imaging.35

MRI has gained popularity as a radiation sparing modality in the evaluation of CD. In a single-center study, a 9-fold increase in MRI was reported among CD patients between 2006 and 2015.36 Despite the increasing use of MRI in the past decade, likely as a result of better availability and insurance precertification, the rising trend of CT scans stays unmatched probably due to its shorter exam time,29 greater accessibility, round-the-clock availability,31 ease in individuals with morbid obesity, and insurance limitations.

Limitation

This study comes with several limitations. The database is based on population-level data centered around diagnoses codes; hence, patient-level details such as, indication, location of imaging, interval between imaging, ordering provider, age at diagnosis of IBD, severity of disease, complication rates, treatment response, and IBD-related surgeries that require individual review of EHR were unavailable. We acknowledge this as a significant limitation, as frequency of imaging could be related to the severity of illness and treatment response rates. It is well known that the effective dose of an abdominal CT is not an absolute value. Patient size, implementation of dose-reduction technologies, and multiphase vs routine CT account for differences in the exposed radiation from abdominal imaging.3 However, the specific type of scan or the exposure from an individual imaging was not available. Further, we could not derive the trends of CTE and MRE specifically due to limitations of coding in the database. However, the code of CT of the abdomen (with or without pelvis) used in the study includes CTE, and similarly, MR of the abdomen (with or without pelvis) also includes MRE.

Despite these limitations, the study describes abdominopelvic imaging trends on a large cohort of IBD patients in a real-world setting. The prevalence of CD and UC in the entire database with 71 829 080 unique adults (not limited to the study population) was 319 per 100 000 and 265 per 100 000, respectively, at the time of the study, which is consistent with the literature.37 Prior studies based on Explorys have also reported prevalence of IBD and celiac disease, which were comparable to national estimates.38,39

Future Directions

While CT has proved critical in the timely management of IBD patients, especially in the ED and inpatient settings,26 it can increase the cumulative radiation exposure in a chronic medical condition. Development of risk-stratification scoring systems could lead to judicious use of CT scans in most clinical settings. Additionally, application of societal guidelines into practice15-17 and EHR-related strategies to calculate the cumulative exposure can help providers to analyze the risk-benefit ratio and search for alternative tests such as MRI and colonoscopy with ileoscopy and capsule endoscopy before ordering imaging with ionizing radiation whenever available.

Conclusions

CT scans have been the cornerstone of medical imaging since 1970s and are an invaluable tool in the clinical decision making of IBD patients. The yearly trend of abdominal CTs continues to increase despite the growing popularity and availability of MRI.29,31 Even though we were unable to adjust for disease severity and complications, the proportion of IBD patients who underwent multiple CT exams (≥5 abdominal CTs) increased substantially in the past decade. Further studies are needed to explore the interventions to improve appropriate imaging utilization in patients with IBD.

Funding

No funding sources declared.

Conflicts of Interest

None declared.

References

1.

Chatu
S
,
Subramanian
V
,
Pollok
RC
Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease.
Aliment Pharmacol Ther.
2012
;
35
:
529
-
539
.

2.

Kroeker
KI
,
Lam
S
,
Birchall
I
, et al. .
Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study.
J Clin Gastroenterol.
2011
;
45
:
34
-
39
.

3.

Smith-Bindman
R
,
Lipson
J
,
Marcus
R
, et al.
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.
Arch Intern Med.
2009
;
169
:
2078
-
2086
.

4.

Ho
IK
,
Cash
BD
,
Cohen
H
, et al.
Radiation exposure in gastroenterology: improving patient and staff protection.
Am J Gastroenterol.
2014
;
109
:
1180
-
1194
.

5.

Shi
L
,
Tashiro
S
Estimation of the effects of medical diagnostic radiation exposure based on DNA damage.
J Radiat Res.
2018
;
59
(
suppl_2
):
ii121
-
ii129
.

6.

Mathews
JD
,
Forsythe
AV
,
Brady
Z
, et al.
Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians.
BMJ.
2013
;
346
:
f2360
.

7.

Shao
YH
,
Tsai
K
,
Kim
S
, et al.
Exposure to tomographic scans and cancer risks.
JNCI Cancer Spectr.
2020
;
4
:
pkz072
.

8.

Duricova
D
,
Burisch
J
,
Jess
T
, et al. ;
ECCO-EpiCom
.
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature.
J Crohns Colitis.
2014
;
8
:
1351
-
1361
.

9.

Desmond
AN
,
McWilliams
S
,
Maher
MM
, et al.
Radiation exposure from diagnostic imaging among patients with gastrointestinal disorders.
Clin Gastroenterol Hepatol.
2012
;
10
:
259
-
265
.

10.

Chang
M
,
Chang
L
,
Chang
HM
,
Chang
F
Intestinal and extraintestinal cancers associated with inflammatory bowel disease.
Clin Colorectal Cancer.
2018
;
17
:
e29
-
e37
.

11.

Horsthuis
K
,
Bipat
S
,
Bennink
RJ
, et al. .
Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies.
Radiology.
2008
;
247
:
64
-
79
.

12.

Puylaert
CA
,
Tielbeek
JA
,
Bipat
S
, et al. .
Grading of Crohn’s disease activity using CT, MRI, US and scintigraphy: a meta-analysis.
Eur Radiol.
2015
;
25
:
3295
-
3313
.

13.

Greenup
AJ
,
Bressler
B
,
Rosenfeld
G
Medical imaging in small bowel Crohn’s disease-computer tomography enterography, magnetic resonance enterography, and ultrasound: “which one is the best for what?”
Inflamm Bowel Dis.
2016
;
22
:
1246
-
1261
.

14.

Bettenworth
D
,
Bokemeyer
A
,
Baker
M
, et al. ;
Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium.
Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review.
Gut.
2019
;
68
:
1115
-
1126
.

15.

Bruining
DH
,
Zimmermann
EM
,
Loftus
EV
Jr
, et al. ;
Society of Abdominal Radiology Crohn’s Disease-Focused Panel
.
Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease.
Radiology.
2018
;
286
:
776
-
799
.

16.

Lichtenstein
GR
,
Loftus
EV
,
Isaacs
KL
, et al.
ACG clinical guideline: management of Crohn’s disease in adults.
Am J Gastroenterol.
2018
;
113
:
481
-
517
.

17.

Maaser
C
,
Sturm
A
,
Vavricka
SR
, et al. ;
European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]
.
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications.
J Crohns Colitis.
2019
;
13
:
144
-
164
.

18.

Szurowska
E
,
Wypych
J
,
Izycka-Swieszewska
E
Perianal fistulas in Crohn’s disease: MRI diagnosis and surgical planning: MRI in fistulazing perianal Crohn’s disease.
Abdom Imaging.
2007
;
32
:
705
-
718
.

19.

IBM Watson Health
.
The IBM explorys platform
. Accessed
February 14, 2020
. https://www.ibm.com/watson-health/about/explorys

20.

Kaelber
DC
,
Foster
W
,
Gilder
J
, et al.
Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data.
J Am Med Inform Assoc.
2012
;
19
:
965
-
972
.

21.

Le Berre
C
,
Ananthakrishnan
AN
,
Danese
S
, et al.
Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment.
Clin Gastroenterol Hepatol.
2020
;
18
:
14
-
23
.

22.

Langevin
C
,
Normandeau
L
,
Bouin
M
Diagnostic radiation exposure in patients with inflammatory bowel disease.
Can J Gastroenterol Hepatol.
2019
;
2019
:
2030735
.

23.

Levi
Z
,
Fraser
E
,
Krongrad
R
, et al.
Factors associated with radiation exposure in patients with inflammatory bowel disease.
Aliment Pharmacol Ther.
2009
;
30
:
1128
-
1136
.

24.

Peloquin
JM
,
Pardi
DS
,
Sandborn
WJ
, et al.
Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease.
Am J Gastroenterol.
2008
;
103
:
2015
-
2022
.

25.

Nguyen
GC
,
Low
D
,
Chong
RY
, et al.
Utilization of diagnostic imaging and ionization radiation exposure among an inflammatory bowel disease inception cohort.
Inflamm Bowel Dis.
2020
;
26
:
898
-
906
.

26.

Israeli
E
,
Ying
S
,
Henderson
B
, et al.
The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease.
Aliment Pharmacol Ther.
2013
;
38
:
513
-
521
.

27.

Mazor
Y
,
Maza
I
,
Kaufman
E
, et al.
Prediction of disease complication occurrence in Crohn’s disease using phenotype and genotype parameters at diagnosis.
J Crohns Colitis.
2011
;
5
:
592
-
597
.

28.

Peyrin-Biroulet
L
,
Harmsen
WS
,
Tremaine
WJ
, et al.
Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970-2004).
Am J Gastroenterol.
2012
;
107
:
1693
-
1701
.

29.

Govani
SM
,
Higgins
PDR
,
Rubenstein
JH
, et al.
CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital.
PLoS One.
2018
;
13
:
e0195022
.

30.

Pavelock
N
,
Masood
U
,
Minchenberg
S
, et al. .
Effects of obesity on the course of inflammatory bowel disease.
Proc (Bayl Univ Med Cent).
2019
;
32
:
14
-
17
.

31.

Ginde
AA
,
Foianini
A
,
Renner
DM
, et al.
Availability and quality of computed tomography and magnetic resonance imaging equipment in U.S. emergency departments.
Acad Emerg Med.
2008
;
15
:
780
-
783
.

32.

Kerner
C
,
Carey
K
,
Mills
AM
, et al.
Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn’s disease.
Clin Gastroenterol Hepatol.
2012
;
10
:
52
-
57
.

33.

Li
S
,
Brantley
E
Malpractice liability risk and use of diagnostic imaging services: a systematic review of the literature.
J Am Coll Radiol.
2015
;
12
:
1403
-
1412
.

34.

Lee
CI
,
Ponce
NA
,
Ettner
SL
, et al.
Ordering of CT by emergency department provider type: analysis of a nationally representative sample.
AJR Am J Roentgenol.
2012
;
199
:
1054
-
1059
.

35.

Geyer
LL
,
Schoepf
UJ
,
Meinel
FG
, et al.
State of the art: iterative CT reconstruction techniques.
Radiology.
2015
;
276
:
339
-
357
.

36.

Kordbacheh
H
,
Baliyan
V
,
Serrao
J
, et al.
Imaging in patients with Crohn’s disease: trends in abdominal CT/MRI utilization and radiation exposure considerations over a 10-year period.
Inflamm Bowel Dis.
2017
;
23
:
1025
-
1033
.

37.

Ng
SC
,
Shi
HY
,
Hamidi
N
, et al.
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Lancet.
2017
;
390
:
2769
-
2778
.

38.

Panhwar
MS
,
Mansoor
E
,
Al-Kindi
SG
, et al.
Risk of myocardial infarction in inflammatory bowel disease: a population-based national study.
Inflamm Bowel Dis.
2019
;
25
:
1080
-
1087
.

39.

Alkhayyat
M
,
Saleh
MA
,
Abureesh
M
, et al.
The risk of acute and chronic pancreatitis in celiac disease.
Dig Dis Sci.
2021
;
66
:
2691
-
2699
.

Author notes

Co-first author.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)